C79.5
Secondary malignant neoplasm of bone and bone marrow
Clinical Classification Guidelines
Excludes Type 1
- secondary carcinoid tumors of bone (C7B.03)
Medical Intelligence & Overview
ICD-10 code C79.5 refers to secondary malignant neoplasm of bone and bone marrow. This condition is characterized by the spread of cancer cells from a primary site to the bones and bone marrow, leading to secondary or metastatic bone cancer. It is a serious health condition often associated with advanced stages of cancer, requiring careful diagnosis and management.
Causes & Symptoms
Clinical Causes: Primary Cancer Spread: The most common cause is the metastasis of primary cancers originating from organs such as the breast, lung, prostate, kidney, or thyroid. These cancers can spread via the bloodstream or lymphatic system to the bones. Advanced Primary Cancers: When a primary tumor grows extensively, cancer cells can invade nearby tissues and spread to distant sites like bones. Lymphatic or Hematogenous Spread: Cancer cells can travel through blood vessels or lymphatic channels, reaching bones and bone marrow. Genetic and Environmental Factors: Certain genetic predispositions and environmental exposures may increase the likelihood of metastasis. Weakened Immune System: A compromised immune system can facilitate the spread of cancer cells to bones.
Key Symptoms: Bone Pain: Persistent or worsening pain, often localized to affected bones. Swelling or Tenderness: Swelling around the affected bones or joints. Pathological Fractures: Bones weakened by cancer may fracture easily with minimal trauma. Anemia: Due to infiltration of the bone marrow by cancer cells, leading to decreased red blood cell production. Fatigue and Weakness: Common symptoms related to anemia and overall disease progression. Weight Loss and Loss of Appetite: Often observed with advanced cancer stages. Neurological Signs: If the spine is affected, nerve compression can cause numbness, weakness, or paralysis.
Diagnostic & Treatment
Diagnosis Path: Medical History and Physical Examination: Initial assessment to identify symptoms and potential cancer history. Imaging Tests: X-rays, MRI, CT scans, and PET scans help visualize bone lesions and detect metastases. Bone Scan: A nuclear imaging test to identify areas of increased bone activity indicative of metastases. Biopsy: Obtaining tissue samples from suspected bone lesions to confirm the presence of malignant cells. Laboratory Tests: Blood tests to evaluate anemia, calcium levels, and markers of bone turnover. Bone Marrow Biopsy: Sometimes performed to assess infiltration within the marrow.
Treatment Protocols: Systemic Therapy: Includes chemotherapy, targeted therapy, or immunotherapy to control primary and metastatic cancer. Hormonal Therapy: May be used if the primary cancer is hormone-sensitive, such as breast or prostate cancer. Radiation Therapy: To relieve pain, reduce tumor size, or prevent fracture in affected bones. Surgical Intervention: May involve stabilizing bones affected by fractures or removing tumor masses. Supportive Care: Includes pain management, medications for bone health (like bisphosphonates), and nutritional support. Clinical Trials: Emerging treatments and experimental therapies may be considered in certain cases.
Clinical Advice & FAQs
Billing Guidance
Is C79.5 a billable ICD-10 code?
Yes, C79.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.5?
Clinical documentation must specify the nature of Secondary malignant neoplasm of bone and bone marrow and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
